The Massachusetts Bay Transportation Authority (MBTA) would keep naloxone nasal spray at every station on its four subway lines and check supplies daily.
Every station on the MBTA’s four subway lines would have two accessible naloxone boxes without alarms. Daily checks would replace used nasal spray, and nearby instructions would explain emergency use.
The MBTA would report to lawmakers on the program’s results and costs 12 to 18 months after it starts, including recommendations for improvement and expansion.
The MBTA would place two accessible, standalone naloxone boxes without alarms at each covered station. The requirement would cover every MBTA Blue Line, Green Line, Orange Line, and Red Line station. Each box would hold two units of 4-milligram naloxone nasal spray and be checked daily to replace used spray. Flyers around the boxes would provide training information, and nearby instructions would explain emergency use.
The MBTA would send a report to the House and Senate clerks and the chairs of their joint committee on mental health, substance use, and recovery. The report would assess how well the station naloxone program works. The report would evaluate benefits and costs and recommend ways to improve the program and expand it to other forms of transportation. The report would be filed no sooner than 12 months and no later than 18 months after the program starts.
No hearings or votes scheduled.